NeuroOne Medical Technologies Corporation (NMTC)
NMTC trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-09-30, https://www.sec.gov/Archives/edgar/data/1500198/000121390025122390/0001213900-25-122390-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-09-30.
Profile
| Field | Value |
|---|---|
| Ticker | NMTC on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001500198 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $9.1M |
| Net income | -$3.6M |
| Operating income | -$4.2M |
| Net margin | -39.6% |
| Operating margin | -46.5% |
| Revenue growth | +163.5% |
| Cash | $6.6M |
| Total assets | $10.8M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 0.7× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | States substantial doubt about continuing as a going concern. "These factors raise substantial doubt about the Company's ability to continue as a going concern." | 10-Q 2026-08-13 |
| Cash and burn | $2.0M cash; operating cash flow -$1.8M a quarter. | Report 2026-06-30 |
| Shares outstanding | 9,105,763 (2026-08-11); 49,999,519 a year earlier; 23,919,184 three years earlier. 1y figure adjusted for splits (1-for-6 overall); 3y figure adjusted for splits (1-for-6 overall). | Cover page 2026-08-11 |
| Reverse splits, 3 years | 1; latest 1-for-6 on 2026-04-16 | Source 2026-04-16 |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 1 424B5 takedowns, 1 at the market | Latest 2026-06-12 |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | Baker Tilly US, LLP, Minneapolis, Minnesota, United States | PCAOB Form AP 2026-01-21 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $737K, sold $55K on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-06-30 | $2.0M | -$2.0M | -$1.1M | $2.0M | No debt tags | $9.5M | 10-Q 2026-08-13 |
| Q2 2026 2026-03-31 | $1.9M | -$2.4M | -$1.3M | $2.8M | No debt tags | $9.2M | 10-Q/A 2026-06-12 |
| Q1 2026 2025-12-31 | $2.9M | -$1.4M | -$3.1M | $3.6M | No debt tags | $8.7M | 10-Q 2026-02-17 |
| Q4 2025 2025-09-30 | $2.7M | -$1.6M | -$1.5M | $6.6M | No debt tags | $9.1M | 10-K 2025-12-17 |
| Q3 2025 2025-06-30 | $1.7M | -$1.5M | -$1.5M | $8.0M | No debt tags | $6.6M | 10-Q 2026-08-13 |
| Q2 2025 2025-03-31 | $1.4M | -$2.3M | -$56K | $1.3M | No debt tags | $5.8M | 10-Q/A 2026-06-12 |
| Q1 2025 2024-12-31 | $3.3M | $1.8M | $208K | $1.1M | No debt tags | $5.7M | 10-Q 2026-02-17 |
| Q4 2024 2024-09-30 | $272K | -$3.4M | -$2.7M | $1.5M | No debt tags | $3.5M | 10-K 2025-12-17 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS SUPPLEMENT | 424B5 | 2026-06-12 |
| Latest annual report AMENDMENT NO. 1 TO FORM 10-K | 10-K/A | 2026-01-23 |
| Latest quarterly / interim QUARTERLY REPORT | 10-Q | 2026-08-13 |
| Latest current report CURRENT REPORT | 8-K | 2026-10-05 |
| Latest proxy PROXY STATEMENT | DEF 14A | 2026-03-09 |
Source: SEC EDGAR submissions feed, 653 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -15.2% |
| 1 month | -32.3% |
| 3 months | -59.3% |
| Year to date | -83.6% |
| 1 year | -81.7% |
| From 52-week high | -87.3% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| CNSY | Cerenome Inc. Common Stock | $0.7148 | -24.77% | $7.0M |
| ARAY | Accuray Incorporated | $2.55 | -8.93% | $7.7M |
| AEMD | Aethlon Medical Inc. | $5.01 | -5.29% | $8.1M |
| WOK | WORK Medical Technology Group LTD | $1.23 | +2.50% | $5.5M |
| PLSM | Pulsenmore Ltd. | $1.41 | +2.17% | $9.2M |
| INBS | Intelligent Bio Solutions Inc. | $1.50 | -16.20% | $5.0M |
| SINT | SiNtx Technologies Inc. | $1.34 | -1.11% | $10.1M |
| ICU | SeaStar Medical Holding Corporation | $0.8535 | +1.80% | $4.5M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier